Request Trial
24 February 2026NewsCareersSarah Speight

Wiggin’s new litigation partner deepens ‘technically complex’ offer

The New York hire brings broad litigation and transactional experience, including advising clients on artificial intelligence, biotech, pharma and chemical matters.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
Clifford Chance recruits new head of Asia-Pac
29 September 2026   As partner and head of IP for the region, the Hong Kong-based hire brings extensive experience advising on the IP aspects of complex corporate transactions and investments.
Careers
Conley Rose welcomes back former employee with legal and business nous
28 September 2026   The returning shareholder’s work spans the patent lifecycle and includes computerised business methods, polymer compositions, and small molecules.
Careers
New UK High Court judge named as replacement for Justice Meade
23 September 2026   Following the prominent patent judge’s promotion to the Court of Appeal, the judiciary has appointed a King’s Counsel with 35 years’ experience as a barrister.


Editor's picks

Inside the deal boom: LSIPR’s five-part M&A series—all in one place
Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026

Editor's picks

Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026
Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026
Regulation & Industry
The buyers' wishlist: What makes a life sciences deal stack up?
25 August 2026
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026

More features

What's AI best at? In-house teams are still learning
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
5 LSPN takeaways: What’s keeping Europe’s IP teams on their toes?
Lilly loses Fed Circ rehearing bid, sparking enablement questions
Westlaw publisher scores landmark AI copyright win in US appeals court
Scientist and Chinese biotech targeted by Beam in secrets suit
Clifford Chance recruits new head of Asia-Pac
Takeda sees off UK challenge to Elvanse SPC